Impact of polymers on crystal growth rate of structurally diverse compounds from aqueous solution

Molecular Pharmaceutics

Volumn 10, Issue 6, 2013, Pages 2381-2393

  Ilevbare, Grace A ^a   Liu, Haoyu ^b   Edgar, Kevin J ^b   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

amorphous formulation; cellulose polymers; crystal growth; hydrophobicity; specific intermolecular interactions; supersaturation

Indexed keywords

CELECOXIB; CELLULOSE DERIVATIVE; EFAVIRENZ; POLYMER; RITONAVIR;

ADSORPTION; AQUEOUS SOLUTION; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRYSTALLIZATION; DISSOLUTION; GROWTH INHIBITION; GROWTH RATE; HYDROPHOBICITY; INFRARED SPECTROSCOPY; IONIC STRENGTH; MOLECULAR INTERACTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STORAGE; SURFACE PROPERTY; SYNTHESIS;

BENZOXAZINES; CRYSTALLIZATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; POLYMERS; PYRAZOLES; RITONAVIR; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFONAMIDES;

EID: 84878634115     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400029v     Document Type: Article

References (59)

1. Dahan, A.; Miller, J. M.; Amidon, G. L. Prediction of solubility and permeability class membership: Provisional BCS classification of the world's oral drugs AAPS J. 2009, 11, 740-746
2. Yu, L.; Amidon, G. L.; Polli, J. E.; Zhao, H.; Mehta, M. U.; Conner, D. P.; Shah, V. P.; Lesko, L. J.; Chen, M.; Lee, V. H. L.; Hussain, A. S. Biopharmaceutics classification system: The scientific basis for biowavier extensions Pharm. Res. 2002, 19, 921-925
3. Amidon, G. L.; Lennernaes, H.; Shah, V. P.; Crison, J. R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in-vitro drug product dissolution and in-vivo bioavailability Pharm. Res. 1995, 12, 413-420
4. Pouton, C. W. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. Sci. 2006, 29, 278-287
5. Yeh, M. K.; Chang, L. C.; Chiou, A. H. Improving Tenoxicam Solubility and Bioavailability by Cosolvent System AAPS PharmSciTech. 2009, 10, 166-171
6. Munjal, B.; Pawar, Y. B.; Patel, S. B.; Bansal, A. K. Comparative oral bioavailability advantage from curcumin formulations Drug Delivery Transl. Res. 2011, 1, 322-331
7. Loftsson, T.; Brewster, M. E. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes J. Pharm. Pharmacol. 2011, 63, 1119-1135
8. Chakrabarti, S.; Belpaire, F. M. Bioavailability of phenytoin in lipid containing dosage forms in rats J. Pharm. Pharmacol. 1978, 30, 330-331
9. Abrams, L. S.; Weintraub, H. S.; Patrick, J. E.; McGuire, J. L. Comparative bioavailability of a lipophilic steroid J. Pharm. Sci. 1978, 67, 1287-1290
10. Stella, V.; Haslam, J.; Yata, N.; Okada, H.; Lindebaum, S. Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule J. Pharm. Sci. 1978, 67, 1375-1377
11. Miller, J. M.; Beig, A.; Carr, R. A.; Webster, G. K.; Dahan, A. The solubility-permeability interplay when using cosolvents for solubilization: Revising the way we use solubility-enabling formulations Mol. Pharmaceutics 2012, 9, 581-590
12. Miller, J. M.; Beig, A.; Krieg, B. J.; Carr, R. A.; Borchardt, T. B.; Amidon, G. E.; Amidon, G. L.; Dahan., A. The solubility-permeability interplay: Mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation Mol. Pharmaceutics 2011, 8, 1848-1856
13. Miller, J. M.; Dahan, A.; Gupta, D.; Varghese, S.; Amidon, G. L. Enabling the intestinal absorption of highly polar antiviral agents: ionpair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir Mol. Pharmaceutics 2010, 7, 1223-1234
14. Evrard, B.; Chiap, P.; DeTullio, P.; Ghalmi, F.; Piel, G.; Van Hees, T.; Crommen, J.; Losson, B.; Delattre, L. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-[beta]-cyclodextrin J. Controlled Release 2002, 85, 45-50
15. Riad, L. E.; Sawchuk, R. J. Effect of polyethylene glycol 400 on the intestinal permeability of carbamazepine in the rabbit Pharm. Res. 1991, 8, 491-497
16. Cuine, J.; Charman, W.; Pouton, C.; Edwards, G.; Porter, C. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs Pharm. Res. 2007, 24, 748-757
17. Katneni, K.; Charman, S. A.; Porter, C. J. H. Impact of cremophor-EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter related events using the reciprocal permeability approach J. Pharm. Sci. 2007, 96, 280-293
18. Dahan, A.; Hoffman, A. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats Eur. J. Pharm. Biopharm. 2007, 67, 96-105
19. Dahan, A.; Miller, J. M.; Hoffman, A.; Amidon, G. E.; Amidon, G. L. The Solubility-Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to Progesterone J. Pharm. Sci. 2010, 99, 2739-2749
20. Yalkowsky, S. H. Perspective on improving passive human intestinal absorption J. Pharm. Sci. 2012, 101, 3047-3050
21. Takano, R.; Takata, N.; Saito, R.; Furumoto, K.; Higo, S.; Hayashi, Y.; Machida, M.; Aso, Y.; Yamashita, S. Quantitative analysis of the effect of supersaturation on in vivo drug absorption Mol. Pharmaceutics 2010, 7, 1431-1440
22. Sugano, K. Introduction to computational oral absorption simulation Expert Opin. Drug Metab. Toxicol. 2009, 5, 252-293
23. Raghavan, S. L.; Trividic, A.; Davis, A. F.; Hadgraft, J. Crystallization of hydrocortisone acetate: influence of polymers Int. J. Pharmaceutics 2001, 212, 213-221
24. Gao, P.; Guyton, M. E.; Huang, T.; Bauer, J. M.; Stefanski, K. J.; Lu, Q. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations Drug Dev. Ind. Pharm. 2004, 30, 221-229
25. Suzuki, H.; Sunada, H. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers Chem. Pharm. Bull. 1998, 46, 482-487
26. Yokoi, Y.; Yonemochi, E.; Terada, K. Effects of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension Int. J. Pharmaceutics 2005, 290, 91-99
27. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Understanding polymer properties important for crystal growth inhibition-Impact of chemically diverse polymers on solution crystal growth of ritonavir Cryst. Growth Des. 2012, 12, 3133-3143
28. Kar, N.; Liu, H.; Edgar, K. J. Synthesis of Cellulose Adipate Derivatives Biomacromolecules 2011, 12, 1106-1115
29. Liu, H.; Ilevbare, G. A.; Cherniawski, B. P.; Ritchie, E. T.; Taylor, L. S.; Edgar, K. J. Synthesis and Preliminary Structure-Property Evaluation of Cellulose ω-Carboxyesters for Amorphous Solid Dispersions Carbohyd. Polym. 2012, 10.1016/j.carbpol.2012.11.049
30. Brunauer, S.; Emmett, P. H.; Teller, E. Adsorption of gases in multimolecular layers J. Am. Chem. Soc. 1938, 60, 309
31. Fedors, R. F. A method for estimating both the solubility parameter and molar volumes of liquids Polym. Eng. Sci. 1974, 14, 147-154
32. Hoffman, J. D. Thermodynamic driving force in nucleation and growth processes J. Chem. Phys. 1958, 29, 1192
33. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Solubility advantage of amorphous pharmaceuticals I. A thermodynamic analysis J. Pharm. Sci. 2009, 99, 1254
34. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Maintaining Supersaturation in Aqueous Drug Solutions-Impact of Different Polymers on Induction Times Cryst. Growth Des. 2013, 13, 740-751
35. Subramanian, N.; Ray, S.; Ghosal, S. K.; Bhadra, R.; Moulik, S. P. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailable of celecoxib Biol. Pharm. Bull. 2004, 27, 1993-1999
36. Rabel, S. R.; Maurin, M. B.; Rowe, S. M.; Hussain, M. Determination of the pKa and pH-solubility behavior of an ionizable cyclic carbamate, (S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3, 1-benzoxazin-2-one (DMP 266) Pharm. Dev. Technol. 1996, 1, 91-95
37. Strickley, R. G. Currently marketed oral lipid-based dosage forms: Drug products and excipients. In Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water Soluble Drugs; Hauss, D., Ed.; CRC Press: Boca Raton, FL, 2007.
38. Casas-Breva, I.; Peris-Vicente, J.; Rambla-Alegre, M.; Carda-Broch, S.; Esteve-Romero, J. Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography Analyst 2012, 137, 4327-4334
39. Lu, G. W.; Hawley, M.; Smith, M.; Geiger, B. M.; Pfund, W. Characterization of a Novel Polymorphic Form of Celecoxib J. Pharm. Sci. 2006, 95, 305-317
40. Radesca, L. A.; Maurin, M. B.; Rabel, S. R.; Moore, J. R. Crystalline efavirenz. U. S. Patent 6673372B1, 2004.
41. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Inhibition of solution crystal growth of ritonavir by cellulose polymers-factors influencing polymer effectiveness CrystEngComm 2012, 14, 6503-6510
42. Alonzo, D. E.; Raina, S.; Zhou, D.; Gao, Y.; Zhang, G. G. Z.; Taylor, L. S. Characterizing the Impact of Hydroxypropylmethyl Cellulose on the Growth and Nucleation Kinetics of Felodipine from Supersaturated Solutions Crys. Growth Des. 2012, 12, 1538-1547
43. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Effect of binary additive combinations on solution crystal growth of the poorly-water soluble drug, ritonavir Crys. Growth Des. 2012, 12, 6050-6060
44. Amis, E. J.; Hu, N.; Seery, T. A. P.; Hogen-Esch, T. E.; Yassini, M.; Hwang, F. Hydrophilic polymers. Associating polymers containing fluorocarbon hydrophobic units Adv. Chem. Ser. 1996, 248, 279-302
45. Arunan, E.; Desiraju, G. R.; Klein, R. A.; Sadlej, J.; Scheiner, S.; Alkorta, I.; Clary, D. C.; Crabtree, R. H.; Dannenberg, J. J.; Hobza, P.; Kjaergaard, H. G.; Legon, A. C.; Mennucci, B.; Nesbitt, D. J. Defining the hydrogen bond: An account (IUPAC technical report) Pure Appl. Chem. 2011, 83, 1619-1636
46. 8(OH)] Am. Mineral. 1998, 83, 569-576
47. Christensen, J. J.; Hansen, L. D.; Izatt, R. M. Handbook of Proton Ionization Heats and Related Thermodynamic Quantities; John Wiley and Sons: New York, 1976.
48. Hoogendam, C. W.; De Keizer, A.; Cohen Stuart, M. A.; Bijsterbosch, B. H.; Smit, J. A.; Van Dijk, J. A. P. P.; Van der Horst, P. M.; Batelaan, J. G. Persistence length of carboxymethyl cellulose as evaluated from size exclusion chromatography and potentiometric titrations Macromolecules 1998, 31, 6297
49. Abbou Oucherif, K.; Raina, S.; Taylor, L. S.; Litster, J. Quantitative Analysis of the Inhibitory Effect of HPMC on Felodipine Crystallization Kinetics Using Population Balance Modeling CrystEngComm 2013, 15, 2197-2205
50. Kubota, N. Effect of impurities on the growth kinetics of crystals Cryst. Res. Technol. 2001, 36, 749-769
51. Kubota, N.; Yokota, M.; Mullin, J. W. Supersaturation dependence of crystal growth in solutions in the presence of impurity J. Cryst. Growth 1997, 182, 86-84
52. Kubota, N.; Yokota, M.; Mullin., J. W. The combined influence of supersaturation and impurity concentration on crystal growth J. Cryst. Growth 2000, 212, 480-488
53. Kubota, N.; Yokota, M.; Doki, N.; Guzman, L. A.; Sasaki, S.; Mullin, J. W. A mathematical model for crystal growth rate hysteresis induced by impurity Cryst. Growth Des. 2003, 3, 397-402
54. Maltesh, C.; Somasundaran, P.; Kularni, R. A.; Gundiah, S. Polymer-polymer complexation in dilute aqueous solutions: Poly(acrylic acid)-poly(ethylene oxide) and poly(acrylic acid)-poly(vinlypyrrolidone) Langmuir 1991, 7, 2108-2111
55. Duro, R.; Souto, C.; Gómez-Amoza, J. L.; Martínez-Pacheco, R.; Concheiro, A. Cellulose ethers-polysorbate 80 interactions. Implications on the stability of pyrantel pamoate suspensions Chem. Pharm. Bull. 1998, 46, 1421-1427
56. Wang, J.; Somasundaran, P. Mechanisms of ethyl(hydroxethyl) cellulose-solid interaction: Influence of hydrophobic modification J. Colloid Interface Sci. 2006, 293, 322-332
57. Afenya, P. M. Adsorption of xanthate and starch on synthetic graphite Int. J. Miner. Process 1982, 9, 303-319
58. Somasundaran, P.; Krishnakumar, S. Adsorption of surfactants and polymers at the solid-liquid interface Colloid. Surf., A 1997, 123-124, 491-513
59. Somasundaran, P.; Huang, L. Adsorption/aggregation of surfactants and their mixtures at solid-liquid interfaces Adv. Colloid Interface Sci. 2000, 88, 179-208